Literature DB >> 18556069

Pharmacologic suppression of oxidative damage and dendritic degeneration following kainic acid-induced excitotoxicity in mouse cerebrum.

Snjezana Zaja-Milatovic1, Ramesh C Gupta, Michael Aschner, Thomas J Montine, Dejan Milatovic.   

Abstract

Intense seizure activity associated with status epilepticus and excitatory amino acid (EAA) imbalance initiates oxidative damage and neuronal injury in CA1 of the ventral hippocampus. We tested the hypothesis that dendritic degeneration of pyramidal neurons in the CA1 hippocampal area resulting from seizure-induced neurotoxicity is modulated by cerebral oxidative damage. Kainic acid (KA, 1 nmol/5 microl) was injected intracerebroventricularly to C57Bl/6 mice. F2-isoprostanes (F2-IsoPs) and F4-neuroprostanes (F4-NeuroPs) were used as surrogate measures of in vivo oxidative stress and biomarkers of lipid peroxidation. Nitric oxide synthase (NOS) activity was quantified by evaluating citrulline level and pyramidal neuron dendrites and spines were evaluated using rapid Golgi stains and a Neurolucida system. KA produced severe seizures in mice immediately after its administration and a significant (p<0.001) increase in F2-IsoPs, F4-NeuroPs and citrulline levels were seen 30 min following treatment. At the same time, hippocampal pyramidal neurons showed significant (p<0.001) reduction in dendritic length and spine density. In contrast, no significant change in neuronal dendrite and spine density or F2-IsoP, F4-NeuroPs and citrulline levels were found in mice pretreated with vitamin E (alpha-tocopherol, 100mg/kg, i.p.) for 3 days, or with N-tert-butyl-alpha-phenylnitrone (PBN, 200mg/kg, i.p.) or ibuprofen (inhibitors of cyclooxygenase, COX, 14 microg/ml of drinking water) for 2 weeks prior to KA treatment. These findings indicate novel interactions among free radical-induced generation of F2-IsoPs and F4-NeuroPs, nitric oxide and dendritic degeneration, closely associate oxidative damage to neuronal membranes with degeneration of the dendritic system, and point to possible interventions to limit severe damage in acute neurological disorders.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18556069      PMCID: PMC2517174          DOI: 10.1016/j.neuro.2008.04.009

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  73 in total

1.  Associative memory formation increases the observation of dendritic spines in the hippocampus.

Authors:  Benedetta Leuner; Jacqueline Falduto; Tracey J Shors
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

2.  Protection against oxidative damage to CNS by alpha-phenyl-tert-butyl nitrone (PBN) and other spin-trapping agents: a novel series of nonlipid free radical scavengers.

Authors:  J M Carney; R A Floyd
Journal:  J Mol Neurosci       Date:  1991       Impact factor: 3.444

3.  Existence of nitric oxide synthase in rat hippocampal pyramidal cells.

Authors:  B Wendland; F E Schweizer; T A Ryan; M Nakane; F Murad; R H Scheller; R W Tsien
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

4.  Characterization of inducible cyclooxygenase in rat brain.

Authors:  C D Breder; D Dewitt; R P Kraig
Journal:  J Comp Neurol       Date:  1995-05-01       Impact factor: 3.215

5.  Optimal time and dosage of phenyl N-tert-butyl nitrone (PBN) for the inhibition of nitric oxide synthase induction in mice.

Authors:  T Miyajima; Y Kotake
Journal:  Free Radic Biol Med       Date:  1997       Impact factor: 7.376

6.  MPTP-induced deficits in motor activity: neuroprotective effects of the spintrapping agent, alpha-phenyl-tert-butyl-nitrone (PBN).

Authors:  A Fredriksson; P Eriksson; T Archer
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

Review 7.  Mitochondrial free radical generation, oxidative stress, and aging.

Authors:  E Cadenas; K J Davies
Journal:  Free Radic Biol Med       Date:  2000-08       Impact factor: 7.376

8.  Free radical production correlates with cell death in an in vitro model of epilepsy.

Authors:  M V Frantseva; J L Velazquez; P A Hwang; P L Carlen
Journal:  Eur J Neurosci       Date:  2000-04       Impact factor: 3.386

9.  Reversible loss of dendritic spines and altered excitability after chronic epilepsy in hippocampal slice cultures.

Authors:  M Müller; B H Gähwiler; L Rietschin; S M Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

Review 10.  Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases.

Authors:  Kathleen S Montine; Joseph F Quinn; Jing Zhang; Joshua P Fessel; L Jackson Roberts; Jason D Morrow; Thomas J Montine
Journal:  Chem Phys Lipids       Date:  2004-03       Impact factor: 3.329

View more
  15 in total

1.  Protective effects of antioxidants and anti-inflammatory agents against manganese-induced oxidative damage and neuronal injury.

Authors:  Dejan Milatovic; Ramesh C Gupta; Yingchun Yu; Snjezana Zaja-Milatovic; Michael Aschner
Journal:  Toxicol Appl Pharmacol       Date:  2011-06-13       Impact factor: 4.219

2.  The Rho-kinase (ROCK) inhibitor Y-27632 protects against excitotoxicity-induced neuronal death in vivo and in vitro.

Authors:  Byeong Tak Jeon; Eun Ae Jeong; Sun-Young Park; Hyeonwi Son; Hyun Joo Shin; Dong Hoon Lee; Hyun Joon Kim; Sang Soo Kang; Gyeong Jae Cho; Wan Sung Choi; Gu Seob Roh
Journal:  Neurotox Res       Date:  2012-07-19       Impact factor: 3.911

Review 3.  Oxidative and nitrative stress in neurodegeneration.

Authors:  Catherine A Cobb; Marsha P Cole
Journal:  Neurobiol Dis       Date:  2015-05-27       Impact factor: 5.996

4.  Morphometric analysis in neurodegenerative disorders.

Authors:  Dejan Milatovic; Thomas J Montine; Snjezana Zaja-Milatovic; Jennifer L Madison; Aaron B Bowman; Michael Aschner
Journal:  Curr Protoc Toxicol       Date:  2010-02

Review 5.  Measurement of isoprostanes as markers of oxidative stress in neuronal tissue.

Authors:  Dejan Milatovic; Michael Aschner
Journal:  Curr Protoc Toxicol       Date:  2009-02

6.  Protection of DFP-induced oxidative damage and neurodegeneration by antioxidants and NMDA receptor antagonist.

Authors:  Snjezana Zaja-Milatovic; Ramesh C Gupta; Michael Aschner; Dejan Milatovic
Journal:  Toxicol Appl Pharmacol       Date:  2009-07-14       Impact factor: 4.219

7.  Nitric oxide regulates activity-dependent neuroprotective protein (ADNP) in the dentate gyrus of the rodent model of kainic acid-induced seizure.

Authors:  Anna S Cosgrave; Jennifer S McKay; Richard Morris; John P Quinn; Thimmasettappa Thippeswamy
Journal:  J Mol Neurosci       Date:  2009-01-07       Impact factor: 3.444

8.  Antioxidant, anticonvulsive and neuroprotective effects of dapsone and phenobarbital against kainic acid-induced damage in rats.

Authors:  Araceli Diaz-Ruiz; Marisela Mendez-Armenta; Sonia Galván-Arzate; Joaquín Manjarrez; Concepción Nava-Ruiz; Iván Santander; Gustavo Balderas; Camilo Ríos
Journal:  Neurochem Res       Date:  2013-06-01       Impact factor: 3.996

9.  Paradoxical relationship between Mn superoxide dismutase deficiency and radiation-induced cognitive defects.

Authors:  Rikki Corniola; Yani Zou; David Leu; John R Fike; Ting-Ting Huang
Journal:  PLoS One       Date:  2012-11-08       Impact factor: 3.240

Review 10.  Isoprostanes and 4-hydroxy-2-nonenal: markers or mediators of disease? Focus on Rett syndrome as a model of autism spectrum disorder.

Authors:  Cinzia Signorini; Claudio De Felice; Thierry Durand; Camille Oger; Jean-Marie Galano; Silvia Leoncini; Alessandra Pecorelli; Giuseppe Valacchi; Lucia Ciccoli; Joussef Hayek
Journal:  Oxid Med Cell Longev       Date:  2013-06-13       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.